Stock Scorecard
Stock Summary for Kamada Ltd (KMDA) - $6.75 as of 10/17/2025 3:23:41 PM EST
Total Score
22 out of 30
Safety Score
46 out of 100
Currently on the following lists
Growth Stock List
Tim's Recommendation
Buy
Growth List Algorithm Criteria for KMDA
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for KMDA
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for KMDA
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for KMDA
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for KMDA (46 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 7 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 1 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for KMDA
Financial Details for KMDA
Company Overview |
|
|---|---|
| Ticker | KMDA |
| Company Name | Kamada Ltd |
| Country | USA |
| Description | Kamada Ltd. is a biopharmaceutical company based in Rehovot, Israel, specializing in the development and commercialization of plasma-derived protein therapies for rare diseases. The company has established a robust pipeline targeting significant unmet medical needs, leveraging its proprietary technology to yield high-quality therapeutic solutions. With a strong commitment to innovation and a strategic focus on advancing patient care, Kamada presents a compelling investment opportunity in the biotechnology sector, particularly for institutional investors seeking exposure to high-growth healthcare markets. As it continues to navigate the evolving landscape of biopharmaceuticals, Kamada is well-positioned for sustained success. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/12/2025 |
Stock Price History |
|
| Last Day Price | 6.75 |
| Price 4 Years Ago | 6.39 |
| Last Day Price Updated | 10/17/2025 3:23:41 PM EST |
| Last Day Volume | 112,449 |
| Average Daily Volume | 66,871 |
| 52-Week High | 8.90 |
| 52-Week Low | 5.08 |
| Last Price to 52 Week Low | 32.87% |
Valuation Measures |
|
| Trailing PE | 21.09 |
| Industry PE | 88.83 |
| Sector PE | 40.29 |
| 5-Year Average PE | -23.33 |
| Free Cash Flow Ratio | 5.87 |
| Industry Free Cash Flow Ratio | 13.45 |
| Sector Free Cash Flow Ratio | 29.76 |
| Current Ratio Most Recent Quarter | 4.00 |
| Total Cash Per Share | 1.15 |
| Book Value Per Share Most Recent Quarter | 4.58 |
| Price to Book Ratio | 1.50 |
| Industry Price to Book Ratio | 11.41 |
| Sector Price to Book Ratio | 32.15 |
| Price to Sales Ratio Twelve Trailing Months | 2.29 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.77 |
| Sector Price to Sales Ratio Twelve Trailing Months | 16.11 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 57,505,000 |
| Market Capitalization | 388,158,750 |
| Institutional Ownership | 49.18% |
Dividends |
|
| Ex-Dividend Date | 3/17/2025 |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.2000 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.20 |
| Trailing Annual Dividend Yield | 2.96% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 1 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | 62.50% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 62.50% |
| Annual Earnings Growth | 74.58% |
| Reported EPS 12 Trailing Months | 0.32 |
| Reported EPS Past Year | 0.26 |
| Reported EPS Prior Year | 0.26 |
| Net Income Twelve Trailing Months | 19,011,000 |
| Net Income Past Year | 14,462,000 |
| Net Income Prior Year | 8,284,000 |
| Quarterly Revenue Growth YOY | 5.40% |
| 5-Year Revenue Growth | 4.82% |
| Operating Margin Twelve Trailing Months | 15.80% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 65,985,000 |
| Total Cash Past Year | 78,435,000 |
| Total Cash Prior Year | 55,641,000 |
| Net Cash Position Most Recent Quarter | 65,985,000 |
| Net Cash Position Past Year | 65,472,000 |
| Long Term Debt Past Year | 12,963,000 |
| Long Term Debt Prior Year | 12,963,000 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 0.95 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 259,464,000 |
| Total Stockholder Equity Prior Year | 244,021,000 |
| Total Stockholder Equity Most Recent Quarter | 259,954,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 31,589,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.55 |
| Free Cash Flow Past Year | 36,854,000 |
| Free Cash Flow Prior Year | -1,535,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.08 |
| MACD Signal | -0.08 |
| 20-Day Bollinger Lower Band | 6.45 |
| 20-Day Bollinger Middle Band | 7.17 |
| 20-Day Bollinger Upper Band | 7.89 |
| Beta | 0.06 |
| RSI | 39.70 |
| 50-Day SMA | 6.78 |
| 150-Day SMA | 5.60 |
| 200-Day SMA | 5.46 |
System |
|
| Modified | 10/18/2025 2:52:26 AM EST |